December 2024
169 articles-

Dec 31 · 02:00Biotechnology Daily
Protein found in hibernating squirrels could become first cataract drug treatment: study
-

Dec 31 · 01:53Biotechnology Daily
Genfit moves to jump-start enrollment in slow-going phase 2 liver failure trial
-

Dec 31 · 01:51Biotechnology Daily
Sanofi lifts lid on MS data behind tolebrutinib’s mixed phase 3 scorecard, plans ‘24 approval filings
-

Dec 31 · 01:48Bio Business News
Vicebio hauls in $100M series B to push RSV combo vaccine through phase 1
-

Dec 31 · 01:46Bio Business News
Stryker strikes again, acquiring brain surgery devicemaker Nico
-

Dec 31 · 01:44Bio Business News
After Alzheimer's stumble, Athira lays off 70% of workforce and pivots to ALS small molecule
-

Dec 31 · 01:43Bio Business News
Politan prevails in Masimo proxy fight, gaining 2 board seats and ousting CEO Joe Kiani
-

Dec 26 · 20:44Biotechnology Daily
Edgewise's stock jumps 50% on the back of safety data for potential heart disease rival to Camzyos
-

Dec 26 · 20:42Biotechnology Daily
In 2 papers, researchers describe potential new neurodegenerative disease treatment approach
-

Dec 26 · 20:40Biotechnology Daily
Aligos' MASH prospect slashes liver fat in phase 2, but stock drops anyway
-

Dec 26 · 20:38Biotechnology Daily
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
-

Dec 26 · 20:36Bio Business News
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
-

Dec 26 · 20:34Bio Business News
Achilles drops cell therapy program, braces for layoffs after missing 'commercial viability' goals
-

Dec 26 · 20:32Bio Business News
Basilea scores $268M BARDA funding deal to work on antifungals, antibiotics
-

Dec 26 · 20:31Bio Business News
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform
-

Dec 26 · 02:39Biotechnology Daily
Awaiting FDA review, Medtronic details study of adaptive neurostimulation in Parkinson’s disease
-

Dec 26 · 02:37Biotechnology Daily
GE HealthCare claims FDA clearance for amyloid imaging software in Alzheimer’s disease
-

Dec 26 · 02:35Biotechnology Daily
Innovent links cytokine fusion protein to responses in colorectal cancer
-

Dec 26 · 02:33Biotechnology Daily
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
-

Dec 26 · 02:31Bio Business News
Inflammation-focused Upstream set to join growing trickle of biotech IPOs
-

Dec 26 · 02:29Bio Business News
NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines
-

Dec 26 · 02:27Bio Business News
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver
-

Dec 26 · 02:25Bio Business News
Capricor sells Europe rights to DMD therapy for $35M as FDA application approaches
-

Dec 24 · 21:17Biotechnology Daily
Drug based on anti-nausea agent reduces Alzheimer's-advancing astrocytes in mice, biotech says